Oramed Pharmaceuticals (ORMP) Change in Cash (2010 - 2026)

Oramed Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at -$32.7 million for Q1 2026.

• Quarterly Change in Cash fell 262.94% year-over-year to -$32.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.3 million (down 209.61% YoY) and the FY2025 annual result came in at -$8.5 million, down 118.68% from the prior year.
• Change in Cash was -$32.7 million for Q1 2026 at Oramed Pharmaceuticals, down from -$6.2 million in the prior quarter.
• Across five years, Change in Cash topped out at $66.2 million in Q2 2024 and bottomed at -$58.7 million in Q2 2025.
• A 5-year average of -$838470.6 and a median of $1.9 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash sank 3301.57% — and 2024, when it soared 481.71%.
• Oramed Pharmaceuticals' Change in Cash stood at $7.3 million in 2022, then plunged by 50.65% to $3.6 million in 2023, then soared by 243.35% to $12.3 million in 2024, then plunged by 150.6% to -$6.2 million in 2025, then tumbled by 425.43% to -$32.7 million in 2026.
• Business Quant data shows ORMP's Change in Cash at -$32.7 million in Q1 2026, -$6.2 million in Q4 2025, and $36.4 million in Q3 2025.